Target intelligence / Profile preview

Novel transcript, antisense to CCDC126 (ENSG00000298406)

Target
ENSG00000298406
Molecular classification
Long non-coding RNA (lncRNA), Natural antisense transcript (NAT)
01

Overview

ENSG00000298406 encodes a long non-coding RNA classified as a natural antisense transcript (NAT) relative to the CCDC126 gene. NATs are a widespread class of transcripts in eukaryotic genomes; they regulate gene expression in cis or trans, often by interacting with the sense transcript. Mechanisms by which NATs regulate gene expression include transcriptional interference, RNA masking, RNA editing, and gene silencing. However, the specific regulatory activity, physiological function, and expression profile of this particular lncRNA have not been characterized. There is no information indicating that this transcript is a direct therapeutic target or functionally associated with disease at this time. In summary, "novel transcript, antisense to CCDC126" refers to a poorly characterized lncRNA; it is not considered a well-defined therapeutic target, and its functional relevance remains unclear based on current public resources.

Other names
Novel transcript, antisense to CCDC126ENSG00000298406
02

Biological functions

Regulation of gene expression (through cis-acting natural antisense mechanisms)Possible transcriptional interference and gene silencing
03

Disease associations

Other (There is no evidence associating this transcript directly to a disease)

Beyond the preview

Go deeper on Novel transcript, antisense to CCDC126 (ENSG00000298406).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to CCDC126 (ENSG00000298406).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call